Program
Download Program
Thursday, September 8, 2022
| Big picture I |
| 08:45-09:30
Room Louis Armand
|
|
|
0
|
Prediciton and precision diagnosis in KTx
O. Aubert
Paris, France |
|
| Donor, graft allocation and perioperative strategies |
| 09:45-11:10
Room Louis Armand
|
|
|
0
09:45 |
Graft allocation: LAS limitation and perspective
C. Lehr
Cleveland, United States |
|
1
10:00 |
United Kingdom Technique of Direct Procurement of Thoracic Organs from DCD donors with ongoing abdominal NRP
M. Hussain7-6, A. Jothidasan7-6, C. Zeschky7, H. Smail7-6, D. Garcia7, J. Dunning7, U. Stock7-6, M. Osman3, C. Johnston4, R. Gourav2, S. Paul2, AJ. Butler2, A. Sewpaul4, B. Stutchfield4, P. Mohite5, C. Watson2, I. Currie4-1, G. Oniscu4, M. Berman3-1
1NHS Blood and Transplant, Bristol 2Addenbrookes Hospital 3Royal Papworth Hospital, Cambridge 4Royal Infirmary of Edinburgh, Edinburgh 5Golden Jubilee National Hospital, Glasgow 6Imperial College 7Royal Brompton and Harefiled Hospital, London, United Kingdom |
|
2
10:06 |
Extending Cold Static Preservation at 10°C to Avoid Overnight Lung Transplantation: A Prospective Multi-Center Proof-of-Concept Clinical Trial
A. Ali1, S. Schwarz2, M. Gil3, J. Yeung1, L. Donahoe1, K. Yasufuku1, A. Pierre1, M. De Perrot2, T. Waddell1, J. Campo De La Cruz3, K. Hoetzenecker2, S. Keshavjee1, M. Cypel1
1Medical University of Vienna, Vienna, Austria 2University of Toronto, Toronto, Canada 3Hospital Univeritario Puerta de Hierro-Majadahonda, Madrid, Spain |
|
0
10:12 |
Donor quality (review)
A. Neyrinck
Leuven, Belgium |
|
3
10:27 |
Six weeks old organ donor successful lung procurement and Six years follow-up of the growing recipient
R. Purmessur1, H. Spencer2, N. Muthialu2, M. Berman1
1Royal Papworth Hospital, Cambridge 2Great Ormond Street Hospital for Children, London, United Kingdom |
|
4
10:33 |
Modelling Lung Allocation Policies Using Discrete Event Simulation
S. Kennedy, W. Scott, L. Freitas, A. Fisher
Newcastle University, Newcastle Upon Tyne, United Kingdom |
|
0
10:33 |
Lung protective metabolism during 10° static preservation improves injured donor lung viability
E. Abdelnour-Berchtold
Lausanne, Switzerland |
|
5
10:48 |
Lung transplantation from controlled and uncontrolled donation after circulatory death donors with prolonged ischemic times managed with ventilation
A. Palleschi3-4, V. Musso3-4, D. Tosi3, L. Morlacchi2, V. Rossetti2, V. Vaira4, A. Zanella1-4, L. Rosso3-4, I. Righi3, P. Mendogni3, M. Nosotti3-4
1Department of Anaesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 2Respiratory Unit and Cystic Fibrosis Adult Center 3Thoracic Surgery and Lung Transplantation Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 4University of Milan, Milan, Italy |
|
6
10:54 |
Safety and feasibility of “robotic lung transplantation”
D. Emerson, J. Thomas, J. Chikwe, N. D'atellis, R. Rampolla, P. Catarino, D. Megna
Cedars-Sinai, Los Angeles, United States |
|
7
11:00 |
Minimally invasive lung transplantation is associated with favorable early outcomes and analgesia use: A matched cohort study
J. Thomas, Q. Chen, A. Roach, A. Pieris, D. Barnes, G. Rowe, G. Gill, A. Alhossan, J. Chikwe, D. Emerson, P. Catarino, R. Rampolla, D. Megna
Cedars-Sinai Medical Center, Los Angeles, United States |
|
| Infectious disease |
| 09:40-11:10
Room Friedrich List
|
|
|
0
09:40 |
COVID impact on LTx
J. Messika
Hôpital BIchat - Claude Bernard, Paris, France |
|
8
09:55 |
Serological and Clinical Efficacy of Three COVID-19 Doses in Lung Transplant Recipients: A French Multicentre Cohort Study
G. Dauriat2, L. Beaumont10, B. Renaud Picrad9, M. Penhouet4, B. Coiffard3, M. Salpin5, X. Demant7, C. Saint Raymond1, N. Carlier6, J. Messika5, M. Reynaud Gaubert3, I. Danner4, F. Galais8, A. Roux10, J. Le Pavec2
1Service de Pneumologie, Centre hospitalo universitaire Grenoble, Grenoble 2Service de Pneumologie, Hôpital Marie Lannelongue, Le Plessis Robinson 3Service de Pneumologie, Assistance publique hopitaux de Marseille-CHU NOrd, Marseille 4Service de Pneumologie, Centre hospitalo universitaire de Nantes, Nantes 5Service de Pneumologie et transplantation pulmonaire, Hopital Bichat -APHP 6Service de Pneumologie, Hopital Cochin - APHP, Paris 7Service de Pneumologie, Hôpital Haut leveque- Université de Bordeaux, Pessac 8Laboratoire de virologie, Hopitaux Universiatires de Strasbourg 9Service de Pneumologie, Hopitaux Universitaires de Strasbourg, Strasbourg 10Service de Transplantation pulmonaire, Hopital Foch, Suresnes, France |
|
9
10:01 |
Impacts on non-COVID respiratory virus infection in the setting of public health COVID-19 mitigation strategies
V. Ramsammy3, J. Ma2, J. Peng2, B. Keller1
1Pulmonary & Critical Care Medicine, Massachusetts General Hospital, Boston 2Biostatistics 3Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, United States |
|
0
10:07 |
Longitudinal analysis of microbiome in Lung Tx
A. Koutsokera
Lausanne, Switzerland |
|
10
10:07 |
Risk factors for antimicrobial resistance digestive colonization in lung transplant recipient: a single center observational study
A. Sandot, N. Grall, T. Goletto, C. Medraoui, E. Atchade, V. Bunel, G. Weisenburger, C. Godet, G. Jebrak, L. Morer, M. Salpin, D. Mouren, C. Thibaut De Menonville, P. Montravers, Y. Castier, P. Mordant, I. Lolom, H. Mal, JC. Lucet, S. Kerneis, J. Messika
Hôpital BIchat - Claude Bernard, Paris, France |
|
11
10:13 |
Characteristics, survival, and outcome of lung transplantation HIV patients in A Multicenter European Study
C. Rouzaud7-5, C. Berastegui12, C. Picard8, R. Vos2, L. Savale4, X. Demant3, A. Bertani11, E. Verschuuren13, P. Jaksch1, A. Reed14, L. Morlacchi10, M. Reynaud-Gaubert6, O. Lortholary7, E. Fadel5, M. Humbert4, J. Gottlieb9, J. Le Pavec5
1Hôpital Universitaire Vienne, Vienne, Austria 2Hôpital Universitaire Louvain, Louvain, Belgium 3Hôpital Haut-Lévêque, Bordeaux 4Hôpital Bicêtre, Le Kremlin-Bicêtre 5Groupe hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis Robinson 6Hôpital Nord, Marseille 7Hôpital Necker, Paris 8Hôpital Foch, Suresnes, France 9Hopital Hanovre, Hanovre, Germany 10Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan 11IRCCS ISMETT, Palerme, Italy 12Hôpital Vall d'Hebron, Barcelone, Spain 13Hôpital Universitaire Groningen, Groningen, The Netherlands 14Hôpital Royal Brompton & Harefield, Londres, United Kingdom |
|
0
10:13 |
Emerging Fungi
S. Bretagne
Paris, France |
|
12
10:13 |
Inhaled voriconazole: an effective novel antifungal delivery method which reduces systemic absorption and toxicity
B. Gardiner1-3, H. Whitford2-3, B. Levvey2-3, S. Ivulich2-3, G. Snell2-3
1Department of Infectious Diseases 2Department of Respiratory Medicine & Lung Transplantation, Alfred Health 3Central Clinical School, Monash University, Melbourne, Australia |
|
0
10:13 |
Phagotherapy for multi resistant Bacteria
B. Guery
Lausanne, Switzerland |
|
| Big Picture II |
| 12:10-13:10
Room Louis Armand
|
|
|
0
|
Past, present and future of lung transplantation
P. Corris
Newcastle, United Kingdom |
|
| Lunch symposium BIOTEST - CMV in the spotlight : what's new in clinical immunology and management ? |
| 12:10-13:10
Room Louis Armand
|
|
|
0
12:10 |
Conceptual aspects of CMV-immune response and future clinical applications
H. Kaminski
Bordeaux, France |
|
0
|
New Therapeutic and Prophylactic Options for Management of Complex CMV Cases
C. Kotton
Boston, United States |
|
| PGD and perioperative strategies |
| 13:30-15:30
Room Louis Armand
|
|
|
0
13:30 |
Heterogenity of PGD
J. Christie
University of Pennsylvania Perelman School of Medicine, Erdenheim, United States |
|
13
13:45 |
LOW TISSUE ISCHEMIA/REPERFUSION INJURY IN LUNG RECIPIENTS SUPPORTED BY EXTRACORPOREAL MEMBRANE OXYGENATION: A SINGLE-CENTER PILOT STUDY
F. Pezzuto2, F. Fortarezza2, F. Lunardi2, E. Faccioli2, G. Lorenzoni2, A. Boscolo1, N. Sella1, D. Gregori2, M. Schiavon2, P. Navalesi3-1, A. Dell'amore2, F. Rea2, F. Calabrese2
1Institute of Anesthesia and Intensive Care, University Hospital of Padova 2Department of Cardiac, Thoracic, Vascular Sciences, and Public Health 3Department of Medicine, University of Padova, Padova, Italy |
|
14
13:52 |
Mechanical circulatory support in lung transplant recipients: Early and long term survival
M. Sachse3, S. Naito3, C. Oelschner3, A. Nolde4, M. Oldigs1, S. Von Weihe2, Y. Alassar3, A. Bernhardt3, H. Reichenspurner3, B. Sill3
1Department of Pulmonology 2Department of Thoracic Surgery, LungenClinic Grosshansdorf, Grosshansdorf 3Department of Cardiovascular surgery 4Department of Pulmonology, UKE, Hamburg, Germany |
|
0
13:59 |
New approaches? Preemptive ECMO/prolonged ECMO, Early renal remplacement and Proning ventilation
A. Benazo
Vienna, Austria |
|
15
13:59 |
Planned and unplanned ECMO use in lung transplant: analysis of risk factors and of short and long-term outcomes
G. Comacchio3, A. Dell'amore3, E. Faccioli3, M. Schiavon3, D. Pittarello1, F. Calabrese2, P. Navalesi1, F. Rea3
1Anaesthesia and Intensive Care Unit - University Hospital of Padua 2Pathology Unit - University Hospital of Padua 3Thoracic Surgery Unit - University Hospital of Padua, Padova, Italy |
|
16
14:06 |
National Outcomes of Simultaneous Lung-Kidney Transplantation versus Isolated Lung Transplantation with Reduced Renal Function
A. Roach2, Q. Chen2, J. Thomas2, G. Rowe2, G. Gill2, A. Peiris2, D. Emerson2, R. Rampolla, J. Chikwe2, P. Catarino2, D. Megna2
1Department of Pulmonology 2Smidt Heart Institute, Department of Cardiac Surgery, Cedars-Sinai Medical Center, Los Angeles, United States |
|
17
14:13 |
Impact of the time of lung transplantation on early prognosis: a multi-center retrospective cohort on CRISTAL French national registry
I. Cavalier13-16, G. Weisenburger19-18, J. Messika19-18-17, D. Bachelet13-16, E. Sage23, O. Mercier4-5, L. Falque3, B. Renaud Picard22, XB. D'journo9, F. Tronc7, F. Le Pimpec-Barthes15, P. Lacoste12, J. Jougon1, R. Vergne25, A. Roux24-27-17, G. Dauriat6, V. Boussaud20, JF. Mornex2-8, A. Olland22-21, A. Tissot12-11, X. Demant1, C. Saint-Raymond3, T. Villeneuve26, M. Reynaud-Gaubert10, A. Roussel14, P. Eloy13-16, P. Mordant14-18-17
1Service des Maladies Respiratoires, Hôpital Haut-Lévêque, CHU Bordeaux, Bordeaux 2Service de Pneumologie, Hôpital Louis Pradel, Bron, Bron 3Service Hospitalier Universitaire Pneumologie Physiologie, Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble Alpes, La Tronche 4School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre 5Dept of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Groupe Hospitalier Paris Saint Joseph, Hôpital Marie Lannelongue 6Division of Lung Transplantation and Thoracic Surgery, Hôpital Marie Lannelongue, Le Plessis-Robinson 7Department of Thoracic Surgery and Lung Transplantation, Hôpital Louis Pradel, Hospices Civils de Lyon 8Université Lyon 1, INRAE, IVPC, UMR754, Université de Lyon, Lyon 9Department of Thoracic Surgery, Aix-Marseille University, North Hospital 10Service de Pneumologie, Équipe de Transplantation Pulmonaire, Centre de Compétences des Maladies Pulmonaires Rares, Aix-Marseille Université-Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, Marseille 11Service de Pneumologie, CHU de Nantes 12UMR S 1087 CNRS UMR 6291, l'Institut du Thorax, Université de Nantes, CHU Nantes, Nantes 13Département d’Epidémiologie Biostatistiques et Recherche Clinique, APHP.Nord-Université de Paris, Hôpital Bichat-Claude Bernard 14Department of Vascular Surgery, Thoracic Surgery, and Lung Transplantation, Bichat Hospital, University of Paris 15Hôpital Européen Georges-Pompidou, Service de chirurgie thoracique 16INSERM CIC-EC 1425, AP-HP. Nord - Université de Paris 17Paris Transplant Group 18Physiopathology and Epidemiology of Respiratory Diseases, UMR1152 INSERM and Université de Paris 19Service de Pneumologie B et Transplantation Pulmonaire, APHP.Nord-Université de Paris, Hôpital Bichat-Claude Bernard 20Service de Pneumologie, Hôpital Cochin, APHP.CUP, Paris 21INSERM (French institute for health and medical research) 1260 Regenerative Nanomedecine, Translational Medicine Federation of Strasbourg, University of Strasbourg 22Pneumology Unit and Strasbourg Lung Transplant Program, Hôpitaux Universitaires de Strasbourg, Strasbourg 23Department of Thoracic Surgery and Lung Transplantation, Hôpital Foch 24Pneumology, Adult Cystic Fibrosis Center and Lung Transplantation Dept, Foch Hospital, Suresnes 25Department of Thoracic Surgery, University Teaching Hospital of Toulouse 26Service de Pneumologie, Pôle des voies respiratoires, Hôpital Larrey, CHU Toulouse, Toulouse 27Université Versailles-Saint-Quentin-en-Yvelines, Versailles, Versailles, France |
|
18
14:20 |
Increasing use of double lung compared to heart-lung transplantation in idiopathic pulmonary arterial hypertension is associated with comparable outcomes
J. Thomas, Q. Chen, A. Roach, G. Rowe, G. Gill, A. Pieris, D. Emerson, R. Rampolla, J. Chikwe, P. Catarino, D. Megna
Smidt Heart Institute, Cedars-Sinai Medical Center, Miami, United States |
|
0
14:27 |
Elastance vs. Volume for matching graft and recipient
H. Roze
Bordeaux, France |
|
0
14:42 |
Per operative Fluid management: debate. Restrictive Fluid management
J. Fessler
Suresnes, France |
|
0
14:57 |
Per operative Fluid management: debate. Permissive Fluid management
O. Collange
Strasbourg, France |
|
| Graft dysfunction: basics of physiopathology |
| 13:30-15:30
Room Friedrich List
|
|
|
0
13:30 |
OB or not OB, that is the question
S. Verleden
brussels, Belgium |
|
19
13:50 |
Assessing the spatial landscape of immune and epithelial cells in chronic lung allograft dysfunction (CLAD) using imaging mass cytometry
B. Renaud-Picard4-3, M. Cheung1, S. Moshkelgosha3, G. Berra3, D. Hwang2, D. Hedley1, S. Juvet3, T. Martinu3
1Ontario Cancer Institute, Princess Margaret Cancer Centre 2Department of Pathology, Sunnybrook Health Sciences Center 3Toronto Lung Transplant Program, Ajmera Transplant Centre, University Health Network, Toronto, Canada 4Strasbourg lung transplant program, Hôpitaux universitaires de Strasbourg, Strasbourg, France |
|
20
13:57 |
Altered Lipid Metabolism in the Follow Up of Cystic Fibrosis Lung Transplant Patients
I. Righi6, L. Rosso9, M. Alessandra5, F. Pivari3, A. Zulueta3, M. Barcella3, C. Loretelli10, A. Caretti3, R. Paroni3, V. Vaira4, L. Morlacchi6, M. Fiorina10, F. Folli8, P. Signorelli3, M. Nosotti9
2"Aldo Ravelli" Center for Neurotechnology & Exp. Brain Therap., University of Study of Milan 3Biochemistry and Molecular Biology Laboratory, Health Science Department, University of Milan, Milan, Italy 4Division of Pathology, University of Milan and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy 5Endocrinol. Metab. Unit, Health Sci. Dep University of Study of Milan 6Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy 7Laboratory of Clinical Biochemistry and Mass Spectrometry, Department of Health Sciences, University of Milan, Milan, Italy 9Thoracic Surgery and Lung Transplant Unit, University of Study of Milan 10UO Endocrinol. Fatebenefratelli-Sacco Hospital, Milan, Milan, Italy |
|
21
14:04 |
Chronic lung allograft dysfunction: Genetic analysis of donor and recipient
A. Sandot12-3, I. Ba10-3, R. Borie13-3, R. Kessler15, M. Reynaud Gaubert7, X. Demant1, L. Falque4, A. Roux16, J. Le Pavec5, A. Tissot9, JF. Mornex6, A. Leborgne17, C. Knoop2, V. Bunel-Gourdy12, V. Boussaud14, P. Mordant11-3, C. Kannengiesser10-3, J. Messika12, F. The Colt Consortium8
1Service de Pneumologie, Hôpital Haut Lêveque, Bordeaux 2Service de Pneumologie, Hopital Erasme, Bruxelles 3Université Paris Cité, Inserm, PHERE, F-75018 Paris 4Service de Pneumologie et Transplantation pulmonaire, Grenoble 5Centre chirurgical Marie Lannelongue, Le Plessis-Robinson France 6Service de Pneumologie, Hospices civils de Lyon, Lyon 7Service de Pneumologie, Hôpital Nord, Marseille 8COLT Consortium 9Service de Pneumologie, CHU de Nantes, Nantes 10Laboratoire de génétique, Hôpital Bichat, APHP 11Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire AP-HP, Hôpital Bichat 12Hopital Bichat, Service de Pneumologie B et Transplantation pulmonaire 13Service de Pneumologie, Hopital Bichat, AP-HP 14Service de Pneumologie, Hôpital Cochin, APHP, Paris 15Service de Pneumologie, Hopital Civil, Stasbourg 16Service de Pneumologie, Hôpital Foch, Suresnes 17Service de Pneumologie, CHU Toulouse, Toulouse, France |
|
0
14:11 |
Complement biology: what a clinician should know?
M. Durey
Paris, France |
|
0
14:31 |
HLA G in Solid Organ Transplantation
N. Rouas Freiss
Paris, France |
|
0
14:51 |
B cell in LTx
S. Brouard
Nantes, France |
|
0
15:11 |
How COPD/IPF physiopathology could help for CLAD ?
B. Crestani
Paris, France |
|
| EVLP |
| 15:45-18:15
Room Louis Armand
|
|
|
0
15:45 |
In practice: Maastricht 1, 2 with EX vivo
M. Cypel
Toronto, Canada |
|
22
16:15 |
Starting an Ex Vivo lung perfusion Program, a single French lung transplant experience
G. Brioude, D. Boulate, A. Fourdrain, D. Trousse, C. Braggio, PA. Thomas, X. D'journo
APHM, Marseille, France |
|
23
16:25 |
Pressure Controlled Hypothermic Lung Perfusion is not better than Cold Storage for Lung Preservation
G. Fadel3, A. Akamkam3, F. Antigny3, J. Adam4, JB. Menager2, E. Fadel2-3, J. Guihaire1-3, O. Mercier2-3
1Cardiac and Vascular Surgery Department 2Department of Thoracic and Heart-Lung Transplantation 3INSERM UMR_S 999, Hôpital Marie Lannelongue, Le-Plessis-Robinson 4Department of Pathology, Groupe Hospitalier Paris Saint Joseph, Paris, France |
|
0
16:35 |
Different strategies of ventilation for EVLP
A. Neyrinck
Leuven, Belgium |
|
24
17:05 |
A cross-circulatory platform for monitoring innate responses in lung grafts
M. Glorion7-3, F. Pascale7-3, J. Estephan3, M. Huriet3, C. Gouin3, C. Urien3, M. Bourge1, F. Blanc2, J. Rivière2, C. Richard4, V. Gelin4, M. Le Guen5-3, A. Magnan6-3, A. Roux6-3, I. Schwartz-Cornil3, E. Sage7-3
1Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-Sur-Yvette 2GABI, Université Paris-Saclay, INRAE, AgroParisTech 3VIM, Université Paris-Saclay, INRAE, UVSQ 4BREED, Université Paris-Saclay, UVSQ, INRAE, Jouy-En-Josas 5Department of Anesthesiology 6Department of Pulmonology 7Department of Thoracic Surgery and Lung Transplantation, Foch Hospital, Suresnes, France |
|
25
17:15 |
Cell type- and time-dependent biological responses in ex vivo perfused lung grafts
C. Gouin2, TP. Vu Manh4, L. Jouneau2-3, C. Bevilacqua1, L. Hannouche2-4, C. Urien2, J. De Wolf7, M. Glorion7, J. Estephan2-7, A. Roux6, A. Magnan6, M. Le Guen5, B. Da Costa2, C. Chevalier2, D. Descamps2, I. Schwartz-Cornil2, M. Dalod4, E. Sage7
1Université Paris-Saclay, INRAE, AgroParisTech, GABI 2Université Paris-Saclay, INRAE, UVSQ, VIM 3Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-En-Josas 4CNRS, Inserm, Aix Marseille University, Centre d'Immunologie de Marseille-Luminy (CIML), Turing Center for Living Systems, Marseille 5Department of Anesthesiology, Foch Hospital 6Department of Pneumology, Foch Hospital 7Department of Thoracic Surgery and Lung Transplantation, Foch Hospital, Suresnes, France |
|
0
17:25 |
Target of treatment during EVLP
L. Liaudet
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland |
|
| Graft dysfunction: biomarkers |
| 15:45-18:15
Room Friedrich List
|
|
|
0
15:45 |
BAL and Risk stratification
T. Martinu
Toronto, Canada |
|
26
16:15 |
Pulmonary transcriptome across phenotypes and endotypes of human chronic lung allograft dysfunction
G. Berra3-2, J. Allen3-2, A. Duong3-2, L. Levy3-2, M. Kawashima3-2, B. Renaud-Picard3-2, R. Ghany3-2, M. Mcinnis1, S. Keshavjee3-2-4, J. Yeung3-2-4, S. Juvet3-2-4, T. Martinu3-2-4
1Department of Medical Imaging, University Health Network, Toronto, ON, Canada 2Toronto General Hospital Research Institute, University Health Network, Toronto, ON 3Toronto Lung Transplant Program, Ajmera Transplant Centre, University Health Network, Toronto, ON 4University of Toronto, Toronto, ON, Canada, Toronto, Canada |
|
27
16:22 |
Validation of a blood gene signature to predict chronic allograft dysfunction in lung transplantation
R. Danger7, E. Durand7, A. Foureau7-6, J. Claustre2, A. Roux10, J. Le Pavec3, B. Coiffard5, B. Renaud-Picard9, JF. Mornex4, C. Dromer1, M. Reynaud-Gaubert5, A. Tissot7-6, A. Magnan10, S. Brouard7
1Service de Pneumologie, Transplantation Pulmonaire, CHU Bordeaux, Bordeaux 2Service Hospitalier Universitaire Pneumologie Physiologie, CHUGA, Grenoble 3Service de Pneumologie et Transplantation Pulmonaire, Hôpital Marie-Lannelongue, Le Plessis-Robisson 4Service de Pneumologie et Transplantation Pulmonaire, CHU de Lyon, Lyon 5Service de Pneumologie et équipe de transplantation pulmonaire, AP-HM Hôpital Nord, Marseille 6Service de Pneumologie et Transplantation Pulmonaire, CHU Nantes 7CR2TI, UMR 1064, ITUN, CHU Nantes, Nantes Université, INSERM 8Cohort in lung transplantation, Nantes 9Service de Pneumologie et Transplantation Pulmonaire, CHU de Strasbourg, Strasbourg 10Service de Pneumologie et Transplantation Pulmonaire, Hôpital Foch, Suresnes, France |
|
28
16:29 |
IMMUNE CHECKPOINTS IN LUNG TRANSPLANTATION: A PRELIMINARY STUDY
I. Righi1, V. Vaira2-4, L. Rosso1-4, S. Ferrero2-4, L. Morlacchi3, V. Rossetti3, M. Nosotti1-4, M. Cattaneo4, V. Musso1-4, M. Clerici4
1Thoracic Surgery and Lung Transplant Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico 2Division of Pathology 3Pulmonology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy 4University of Study of Milan, Milan, Italy |
|
0
16:36 |
Non HLA DSA
A. Zeevi
Pittsburgh, United States |
|
29
17:06 |
EARLY DONOR-SPECIFIC ANTIBODIES AND REJECTION AFTER TRANSPLANTATION: THE UNSUSPECTED ROLE OF INVERTED DIRECT ALLORECOGNITION
X. Charmetant8, CC. Chen16, S. Hamada4-8, C. Saison4, M. Rabeyrin3, M. Rabant11, JP. Duong Van Huyen11, L. Chalabreysse3, F. Lacaille13, JF. Mornex2-9, J. Le Pavec5, O. Brugière15, P. Mordant10, JL. Taupin12, A. Nicoletti14, V. Dubois4, L. Couzi1, L. Badet7, E. Morelon6-9, O. Thaunat6-9-8
1Department of Nephrology, Transplantation, Dialysis, Apheresis, Pellegrin Hospital, Bordeaux 2Department of Pneumology, Groupement Hospitalier Est, Hospices Civils de Lyon 3Department of Pathology, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron 4HLA Laboratory, French National Blood Service (EFS), Décines 5Dept of Pulmonology and Lung Transplantation, Marie Lannelongue Hospital, Le Plessis Robinson 6Department of Transplantation, Nephrology and Clinical Immunology 7Department of Urology and Transplantation Surgery, Hospices Civils de Lyon, Edouard Herriot Hospital 8INSERM U1111 - Centre International de Recherche en Infectiologie 9Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon 10Department of Vascular and Thoracic Surgery, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard Hospital 11Department of Pathology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker 12Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris 13Pediatric Gastroenterology-Hepatology-Nutrition Unit, Hôpital Universitaire Necker-Enfants malades 14LVTS, INSERM U1148, Université de Paris, Paris 15Pulmonology Department, Adult Cystic Fibrosis Centre and Lung Transplantation Department, Foch Hospital, Suresnes, France 16Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan |
|
0
17:13 |
cfDNA in LTx: now and after
S. Agbor
Bethesda, United States |
|
30
17:43 |
Insights into the lung microenvironment: deciphering the role of BAL-Evs allograft Rejection
V. Vaira6, A. Palleschi2-6, AM. Storaci6, S. Franzi2, V. Musso2, R. Bruschi1, LC. Morlacchi4, V. Rossetti4, F. Blasi3-6, M. Nosotti2-6, S. Bosari6, S. Ferrero1-5
1Division of Pathology 2Division of Thoracic Surgery and Lung Transplantation 3Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center 4Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico 5Department of Dental Sciences, Università degli Studi di Milano 6Department of Pathophysiology and Transplantation, Università degli studi di Milano, Milan, Italy |
|
31
17:50 |
cfDNA quantification and qualification in the diagnosis of acute rejection after lung transplantation
B. Coiffard1, M. Reynaud-Gaubert1, L. Hubert2-3, A. Basire2, S. Simon2, J. Chiaroni2-3, C. Frassati2-3, P. Pedini2-3, C. Picard2-3
1Department of Respiratory Medicine and Lung Transplantation, Assistance Publique - Hôpitaux de Marseille 2Laboratory of Immunogenetics, Établissement Français du Sang 3ADES UMR 7268, Université Aix Marseille, Marseille, France |
|
Friday, September 9, 2022
| New frontiers in indications |
| 8:30-10:30
Room Louis Armand
|
|
|
32
8:30 |
Outcomes of lung transplantation for recipients of 60 years old and more, results from COLT
A. Tissot7, P. Lacoste7, B. Guyomarch7, B. Coifard6, B. Renaud-Picard6, A. Roux11, X. Demant1, J. Le Pavec4, J. Messika8, L. Falque3, JF. Mornex5, A. Leborgne-Krams, V. Boussaud9, C. Knoop2, A. Foureau7, A. Magnan11, FX. Blanc7
1Centre Hospitalier Universitaire de Bordeaux, Bordeaux 2Hôpitale Erasme, Brussels 3Centre Hospitalier Universitaire de Grenoble-Alpes, Grenoble 4Hôpital Marie-Lannelongue, Le Plessis Robinson 5Hospices Civils de Lyon, Lyon 6Centre Hospitalier Universitaire Nord de Marseille, Marseille 7Centre Hospitalier Universitaire de Nantes, Nantes 8Hôpital Bichat, Assistance Publique-Hôpitaux de Paris 9Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris 10Centre Hospitalier Universitaire de Strasbourg, Strasbourg 11Hôpital Foch, Suresnes, France |
|
0
08:30 |
LTx for ARDS (COVID and non COVID)
A. Frick
Vienna, Austria |
|
0
08:50 |
Acute ILD MdA5
Y. Allenbach
Paris, France |
|
33
09:10 |
Lung Transplantation for Interstitial Lung Disease in Idiopathic Inflammatory Myositis: A Cohort Study
A. Rivière5, C. Picard19, C. Berastegui24, VM. Mora25, V. Bunel13, L. Godinas3, E. Salvaterra21, V. Rossetti22, L. Savale7-8-10, D. Israel-Biet14, X. Demant18, J. Bermudez12, F. Meloni23, P. Jaksch1, J. Magnusson26, L. Beaumont19, M. Perch4, JF. Mornex6-11, C. Knoop2, JD. Aubert27, B. Hervier15-16, H. Nunes5-17, M. Humbert7-8-10, J. Gottlieb20, Y. Uzunhan5-17, J. Le Pavec9-8-10
1Medical University of Vienna, Vienna, Austria 2Erasme University, Brussels 3University Hospital Leuven, Leuven, Belgium 4Copenhagen University Hospital, Copenhagen, Denmark 5AP-HP, CHU Avicenne, Bobigny 6Louis Pradel Hospital, Bron 7AP-HP, CHU Bicètre 8Université Paris–Sud, Kremlin - Bicêtre 9Marie Lannelogue Hospital 10Université Paris–Sud, Le Plessis-Robinson 11Université de Lyon, Lyon 12AP-HM, CHU Nord, Marseille 13AP-HP, CHU Bichat 14AP-HP, CHU Georges Pompidou European Hospital 15AP-HP, CHU Saint-Louis 16Université de Paris 17Université Sorbonne Paris Nord, Paris 18Haut-Lévèque Hospital, Pessac 19Foch Hospital, Suresnes, France 20Hannover Medical School, Hannover, Germany 21IRCCS Azienda ospedaliero-universitaria di Bologna, Bologne 22IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 23IRCCS Policlinico San Matteo Foundation, Pavia, Italy 24Hospital Vall d'Hebron, Barcelona 25Hospital Marqués de Valdecilla, Santander, Spain 26Institute of Medicine, University of Gothenburg, Göteborg, Sweden 27Lausanne University Hospital, Lausanne, Switzerland |
|
34
09:20 |
Outcomes of lung transplantation for pleuroparenchymal fibroelastosis : a French multicentric study.
H. Clermidy3, G. Brioude5, A. Roussel7, C. Picard12, O. Mercier9, G. Le Pavec9, A. Roux12, E. Fadel9, M. Reynaud-Gaubert6, J. Messika8, A. Olland10, X. Demant2, T. Degot10, J. Jougon1, P. Mordant7, E. Sage11, P. Thomas5, V. Cottin4, F. Tronc3
1Service de chirurgie thoracique, Hôpital Haut Leveque 2Service des Maladies Respiratoires, Hôpital Haut Leveque, CHU Bordeaux, Bordeaux 3Department of Thoracic Surgery and Lung Transplantation, Hôpital Louis Pradel 4Service de Pneumologie, Centre de référence des Maladies Pulmonaires Rares, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron 5Department of Thoracic Surgery 6Service de Pneumologie, Équipe de Transplantation Pulmonaire, Centre de Compétences des Maladies Pulmonaires Rares, North Hospital, Marseille 7Department of Vascular Surgery, Thoracic Surgery, and Lung Transplantation 8Service de Pneumologie B et Transplantation Pulmonaire, Bichat Hospital, Paris 9Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Groupe Hospitalier Paris Saint Joseph, Hopital Marie Lannelongue, Plessis Robinson 10Pneumology Unit and Strasbourg Lung Transplant Program, Hôpitaux Universitaires de Strasbourg, Strasbourg 11Department of Thoracic Surgery and Lung Transplantation 12Pneumology, Adult Cystic Fibrosis Center and Lung Transplantation Dept, Foch Hospital, Suresnes, France |
|
0
09:30 |
LTx for PH ealier the better?
L. Savale
Paris, France |
|
35
09:50 |
Bilateral lung transplantation in severe chest asymmetry
L. Rosso, P. Mendogni, A. Palleschi, D. Tosi, I. Righi, G. Grasselli, L. Morlacchi, C. Diotti, A. Mazzucco, M. Nosotti
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy |
|
36
10:00 |
Effect of CLAD phenotypes on the outcome after lung retransplantation – a retrospective single center data analysis
S. Auner, PM. Böhm, S. Schwarz, T. Schweiger, AE. Frick, MA. Hoda, B. Moser, JR. Matilla, G. Muraközy, G. Lang, S. Taghavi, W. Klepetko, P. Jaksch, K. Hötzenecker, A. Benazzo
Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria |
|
0
10:10 |
CF and CFTR modulator
A. Koutsokera
Lausanne, Switzerland |
|
| Graft dysfunction: clinical practice |
| 10:45-12:45
Room Louis Armand
|
|
|
0
10:45 |
Redesign/Reassess graft dysfunction (active/non active)
D. Levine
San Francisco, United States |
|
37
11:05 |
Assessing Allograft Outcome – Are % Baseline FEV1 Values Necessary?
M. Greer, A. Haverich, T. Welte, CS. Falk, F. Ius
Hannover Medical School, Hannover, Germany |
|
0
11:12 |
LASHA: standardized template for TBB analysis
F. Calabrese
Padova, Italy |
|
38
11:32 |
Prognostic value of cumulative Acute Cellular Rejection “A-score” for CLAD and graft survival following lung transplantation
N. Belousova5-3, E. Huszti1, Q. Li1, R. Gabarin4, A. Vasileva2, L. Levy6, R. Ghany3, M. Aversa3, CWC. Chow3-2, T. Martinu3, A. Roux5
1Biostatistics Research Unit, University Health Network 2Division of Respirology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto 3Toronto Lung Transplant Program, Ajmera Multi-Organ Transplant Program and Division of Respirology, University Health Networ 4University of Toronto, Toronto, Canada 5Hôpital Foch, Suresnes, France 6Institute of Pulmonary Medicine, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv, Israel |
|
0
11:39 |
CNI free strategies in LTX
J. Gottlieb
Hannover, Germany |
|
39
11:59 |
Extracorporel photoapheresis induced modulation of exosomal-miRNas, cytokines and growth factor expression by peripheral blood mononuclear cells in CLAD patients.
C. Bagnera, E. Bozza, S. Bozzini, C. Del Fante, M. De Amici, G. Testa, V. Vertui, M. Morosini, G. Viarengo, R. Cacciatore, C. Perotti, F. Meloni
IRCCS Policlinico San Matteo, Pavia, Pavia, Italy |
|
40
12:06 |
LONG TERM USE OF AZITHROMYCIN IN LUNG TRANSPLANT RECIPIENTS
LC. Morlacchi1, V. Rossetti1, F. Damarco2, R. Carrinola2, F. Blasi1
1Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Centre 2Thoracic Surgery and Lung Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy |
|
0
12:13 |
How to monitor your patient (Torque virus, T0, BAL, TBB, DSA….)
P. Jaksch
Vienna, Austria |
|
41
12:33 |
TELEMONITORING: improving multidisciplinary care in lung transplanted patients
LC. Morlacchi2, V. Rossetti2, M. Santambrogio1, A. Palleschi3, L. Rosso3, E. Privitera1, F. Blasi2
1Health and Care Professions Department 2Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Centre 3Thoracic Surgery and Lung Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy |
|
| Next future |
| 14:00-15:30
Room Louis Armand
|
|
|
0
|
How to reach 100 translantation/year
A. Jauregui
Barcelona, Spain |
|
0
|
Update on Xenogeneic Transplantation as Treatment for End Stage Organ Failure
M. Lorber
New York, United States |
|
0
|
Graft gene expression: the kidney way
D. Zielinski
Paris, France |
|
| Panel discussion and conclusion |
| 15:30-16:00
Room Louis Armand
|
|
|
Version Française